Medications for Paroxysmal Extreme Pain Disorder

7 results
  • Sun Pharmaceutical Industries, Inc.
    Usage: Bromfenac ophthalmic solution 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.
  • Amneal Pharmaceuticals NY LLC
    Usage: Bromfenac ophthalmic solution, 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
  • Lupin Pharmaceuticals Inc
    Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
  • Dr. Reddy's Laboratories Inc.
    Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
  • Bausch & Lomb Americas Inc.
    Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
  • Pacific Pharma, Inc.
    Usage: Ketorolac tromethamine ophthalmic solution is indicated for reducing ocular pain and burning/stinging after corneal refractive surgery.
  • Bausch & Lomb Americas Inc.
    Usage: Loteprednol Etabonate Ophthalmic Gel is a corticosteroid used to treat post-operative inflammation and pain following ocular surgery.